AU2001264659A1 - Isolation of genes within sle-1b taht mediate a beak in immune tolerance - Google Patents

Isolation of genes within sle-1b taht mediate a beak in immune tolerance

Info

Publication number
AU2001264659A1
AU2001264659A1 AU2001264659A AU6465901A AU2001264659A1 AU 2001264659 A1 AU2001264659 A1 AU 2001264659A1 AU 2001264659 A AU2001264659 A AU 2001264659A AU 6465901 A AU6465901 A AU 6465901A AU 2001264659 A1 AU2001264659 A1 AU 2001264659A1
Authority
AU
Australia
Prior art keywords
taht
beak
sle
mediate
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001264659A
Inventor
Laurence Morel
Edward K. Wakeland
Amy Wandstrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of AU2001264659A1 publication Critical patent/AU2001264659A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001264659A 2000-05-17 2001-05-17 Isolation of genes within sle-1b taht mediate a beak in immune tolerance Abandoned AU2001264659A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US20496300P 2000-05-17 2000-05-17
US60/204,963 2000-05-17
US23445700P 2000-09-21 2000-09-21
US60/234,457 2000-09-21
PCT/US2001/016051 WO2001088200A2 (en) 2000-05-17 2001-05-17 Isolation of genes within sle-1b taht mediate a beak in immune tolerance

Publications (1)

Publication Number Publication Date
AU2001264659A1 true AU2001264659A1 (en) 2001-11-26

Family

ID=26899946

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001264659A Abandoned AU2001264659A1 (en) 2000-05-17 2001-05-17 Isolation of genes within sle-1b taht mediate a beak in immune tolerance

Country Status (3)

Country Link
US (1) US20030054002A1 (en)
AU (1) AU2001264659A1 (en)
WO (1) WO2001088200A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040109863A1 (en) * 2002-12-04 2004-06-10 Peter Emtage Methods of therapy and diagnosis using targeting of cells that express Ly-9
WO2009067755A1 (en) * 2007-11-30 2009-06-04 The University Of Melbourne Therapeutic targets and medicaments involving p230/golgin-245
EP2352998A4 (en) * 2008-11-07 2011-09-21 Centocor Ortho Biotech Inc Markers and methods for assessing and treating lupus patients susceptible to photoprovocation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576423A (en) * 1994-12-02 1996-11-19 Schering Corporation Antibodies to the slam protein expressed on activated T cells
GB9711040D0 (en) * 1997-05-29 1997-07-23 Duff Gordon W Prediction of inflammatory disease
US6162604A (en) * 1999-04-01 2000-12-19 Jacob; Chaim O. Methods for determining genetic predisposition to autoimmune diseases by genotyping apoptotic genes

Also Published As

Publication number Publication date
WO2001088200A3 (en) 2003-09-12
US20030054002A1 (en) 2003-03-20
WO2001088200A2 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
AU3719500A (en) Recombination of insertion modified nucleic acids
AU2001286420A1 (en) Modular connector
AU2001288720A1 (en) Implantable article
AU2001235360A1 (en) Fermentation with a phytase
AU2002220553A1 (en) Bioreactor
AU2001227900A1 (en) Drug metabolizing enzymes
AU2001274981A1 (en) Drug metabolizing enzymes
AUPQ520800A0 (en) Prime-boost vaccination strategy
AU5260200A (en) A method of transferring individual objects to a pallet-loaded unit
AU2001290877A1 (en) Gridbloc strategy game
AU2001264659A1 (en) Isolation of genes within sle-1b taht mediate a beak in immune tolerance
AUPQ948800A0 (en) A vaccine strategy
AU2001231053A1 (en) Lipid metabolism enzymes
AU2001235000A1 (en) Drug metabolizing enzymes
AU2001255324A1 (en) Drug metabolizing enzymes
AU2400401A (en) Novel phosphodiesterases and genes thereof
AU3411400A (en) Transformation of monocotyledoneous plants using agrobacterium
AU2001278154A1 (en) Drug metabolizing enzymes
AU2002216479A1 (en) Isolation method
AU2001247453A1 (en) Genetically stable cholera vaccines
AU2001273951A1 (en) Steam injector
AU2001281048A1 (en) Floral induction gene
AU2001296607A1 (en) High efficiency regulatable gene expression system
AU2001261424A1 (en) Lipid metabolism enzymes
AU2569200A (en) High isolation couplers